The effects of vasoactive drugs on reticuloendothelial function in experimental shock and combined injury.
D000804:Angiotensin II / Q000494:pharmacology*; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D005260:Female; D007422:Intestines / Q000098:blood supply; D007511:Ischemia; D012157:Mononuclear Phagocyte System / Q000187:drug effects* / Q000503:physiopathology; D009638:Norepinephrine / Q000494:pharmacology*; D010587:Phagocytosis / Q000187:drug effects; D051381:Rats; D012771:Shock, Hemorrhagic / Q000150:complications / Q000209:etiology / Q000401:mortality / Q000503:physiopathology*; D012774:Shock, Traumatic / Q000150:complications / Q000209:etiology / Q000401:mortality / Q000503:physiopathology*; D012964:Sodium / Q000494:pharmacology; D014667:Vasopressins / Q000494:pharmacology*
D014667:Vasopressins; D000804:Angiotensin II; D012964:Sodium; D009638:Norepinephrine